Načítá se...
Informed Consent and Decision Making Among Participants in Novel-Design Phase I Oncology Trials
BACKGROUND: Although phase I clinical trials are the gateway to progress in cancer therapies, this setting poses ethical challenges to ensure that patients provide consent free from misunderstandings of therapeutic intent or unrealistic expectations of benefit. The design of phase I oncology trials...
Uloženo v:
| Vydáno v: | J Oncol Pract |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society of Clinical Oncology
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5640413/ https://ncbi.nlm.nih.gov/pubmed/28837373 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.2017.021303 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|